Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Gains from Investment Securities (2019 - 2025)

Historic Gains from Investment Securities for LifeMD (LFMDP) over the last 10 years, with Q2 2025 value amounting to $1.2 million.

  • LifeMD's Gains from Investment Securities rose 1862.57% to $1.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.2 million, marking a year-over-year decrease of 4818.83%. This contributed to the annual value of $682333.0 for FY2024, which is 33973.82% up from last year.
  • Latest data reveals that LifeMD reported Gains from Investment Securities of $1.2 million as of Q2 2025, which was up 1862.57% from $725000.0 recorded in Q1 2025.
  • LifeMD's 5-year Gains from Investment Securities high stood at $4.4 million for Q3 2024, and its period low was -$2.6 million during Q4 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $1.3 million (2024), whereas its average is $1.2 million.
  • Per our database at Business Quant, LifeMD's Gains from Investment Securities tumbled by 9694.83% in 2023 and then skyrocketed by 691523.86% in 2024.
  • Over the past 5 years, LifeMD's Gains from Investment Securities (Quarter) stood at $2.1 million in 2021, then plummeted by 224.8% to -$2.6 million in 2022, then soared by 102.37% to $62053.0 in 2023, then crashed by 265.37% to -$102618.0 in 2024, then soared by 1308.37% to $1.2 million in 2025.
  • Its Gains from Investment Securities was $1.2 million in Q2 2025, compared to $725000.0 in Q1 2025 and -$102618.0 in Q4 2024.